Atria is entering the poultry business in Sweden - Atria to purchase Lagerberg i Norjeby AB, a Swedish poultry business.
March 11, 2016 01:55 ET
|
Atria Oyj
Seinäjoki, Finland, 2016-03-11 07:55 CET (GLOBE NEWSWIRE) --
Atria Plc, Company Announcement 11 March 2016 at 8.55 am
Atria is entering the poultry business in Sweden - Atria to purchase...
Lindab International AB: The Nomination Committee's proposal regarding election of Board of Directors
March 11, 2016 01:40 ET
|
Lindab International AB
11 March 2016 The Nomination Committee in Lindab International AB (publ) consists of Peter Rönström (chair), representing Lannebo Fonder, Per Frankling, representing Creades AB, Per Colleen,...
Boussard & Gavaudan Holding Ltd (GBP): NAV(s)
March 11, 2016 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
BOUSSARD...
Boussard & Gavaudan Holding Ltd (EUR): NAV(s)
March 11, 2016 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
BOUSSARD...
Revenio Group Corporation: Share repurchase 10.3.2016
March 11, 2016 01:30 ET
|
Revenio Group Corporation
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Revenio Group Corporation, Stock...
Pihlajalinna Plc:Notice to the Annual General Meeting
March 11, 2016 01:15 ET
|
Pihlajalinna Oyj
Pihlajalinna Plc Stock Exchange Release 11 March 2016 at 8.15 EET Pihlajalinna Plc: Notice to the Annual General Meeting Notice is given to the shareholders of Pihlajalinna Oyj to the Annual...
Sanofi and Regeneron Announce Topline Results of Phase 3 Monotherapy Study Demonstrating Superiority of Sarilumab vs. Adalimumab in Patients with Active Rheumatoid Arthritis
March 11, 2016 01:00 ET
|
Sanofi - Aventis Groupe
Sanofi and Regeneron Announce Topline Results of Phase 3 Monotherapy Study Demonstrating Superiority of Sarilumab vs. Adalimumab in Patients with Active Rheumatoid Arthritis Paris, France and...
AMG Reports Full Year and Fourth Quarter 2015 Results; Ends Year Net Debt Free -- Ready for Growth
March 11, 2016 01:00 ET
|
AMG Critical Materials N.V.
Key Highlights AMG ended the year net debt free, reducing net debt by $88.9 million in 2015, or $3.22 per ordinary share Fourth quarter 2015 cash flows from operating activities were $33.6...
argenx reports fourth quarter business update and full year 2015 financial results
March 11, 2016 01:00 ET
|
argenx SE
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Clinical programs in severe auto-immune...
Incap Corporation: Notice to Annual General Meeting
March 11, 2016 01:00 ET
|
Incap Oyj
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Incap Corporation Stock Exchange...
- June 02, 2024 19:00 ET Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- June 02, 2024 17:07 ET Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year